Atlas Trials

Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access

Clinical trial NCT04489849 · UNKNOWN

Trial details

NCT number
NCT04489849
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hemodialysis Access Failure
Start date
2020-03-14
Primary completion
2022-03-14
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.